On Thursday, for the second time, Ron Paul, the libertarian political rock-star and father of Rand, hosted a reddit AMA (or, Ask Me Anything, for the layman). Paul, who retired from the House at the end of the last Congress, is using the platform to get some hype for his new online channel, aptly named The Ron Paul Channel. Paul describes the channel, and his upcoming AMA in a video on reddit’s YouTube page:
In a quick video, Ron Paul runs through his values he hopes to talk to reddit users about:
Ending the senseless war on drugs, fighting for personal freedom, opposing the police and surveillance state, exposing government corporate collusion, and getting America to stop making war on the world.
If that list isn’t a fine way of pandering to reddit, then no list is a fine way of pandering to reddit.
Some corners of reddit started getting the engine running early for the AMA, such as r/Bitcoin, which called this “a perfect opportunity to promote Bitcoin,” and r/conspiracy, where a redditor said it “might be a good time to get a clarification of [Paul’s] stance on 9/11 Truth and its implications on the future of our society.” Ron Paul was a little late to start the actual AMA, which resulted in an all caps, AMA Request: WE WANT RON PAUL WE WANT RON PAUL.
The people of reddit want their Ron Paul. Here are the best things they asked him, and the best responses. We’ll update as they come in.
First up, Bitcoin! Ron Paul supports other currencies.
Paul also commented on the sentencing of Chelsea Manning, formerly Bradley Manning. Paul thinks she should be “released now.”
Paul also took the time to humbly answer this question about bravery:
Being on the Internet, the former Congressman also managed to squeeze in a zinger:
Oh, and those 9/11 truthers made it in.
But no answer from Paul. Yet.
The former presidential candidate took on Manning again, and Edward Snowden. He says whistle-blowers “obviously ought to be protected”
And, to the disappointment of his audience, Ron Paul shot down any possible 2016 presidential bid:
Paul also talked about his favorite president: Grover Cleveland.
And is Ron Paul just a creation of the Internet? He takes on the conspiracy.
And an answer to a universal, political mystery: what kind of name is Rand? A physician’s name, apparently.
To no one’s surprise, Ron Paul also reaffirmed his stance on marijuana legalization, and predicted that “at some point in the near future there will not be much enforcement of the federal laws against marijuana.”
He so far, however, hasn’t answered this:
But this question kind of summed up much of the feeling about Paul during the AMA:
Or this comment:
What We're Following See More »
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.